US Stock Futures Edge Lower Ahead Of Economic Data

Pre-open moversUS stock futures traded slightly lower in early pre-market trade. Data on weekly jobless claims and the Chicago Fed activity index for April will be released at 8:30 a.m. ET. The PMI manufacturing index for May will be released at 9:45 a.m. ET. Data on existing home sales for April and leading indicators for April will be released at 10:00 a.m. ET. The Kansas City Fed manufacturing index for May will be released at 11:00 a.m. ET. Futures for the Dow Jones Industrial Average dropped 14.50 points to 18,241.50, while the Standard & Poor's 500 index futures slipped 2.35 points to 2,120.15. Futures for the Nasdaq 100 index dipped 9.40 points to 4,496.10.A Peek Into Global MarketsEuropean markets were mixed today, with the Spanish Ibex Index falling 0.16 percent, STOXX Europe 600 Index gaining 0.05 percent and German DAX 30 index dropping 0.37 percent. French CAC 40 Index slipped 0.25 percent and London's FTSE 100 Index rose 0.05 percent.In Asian markets, Japan's Nikkei Stock Average rose 0.03 percent, China's Shanghai Composite Index climbed 1.87 percent, Hong Kong's Hang Seng Index dropped 0.22 percent and India's BSE Sensex slipped 0.10 percent.Broker RecommendationAnalysts at Cantor Fitzgerald downgraded NetApp Inc. (NASDAQ: NTAP) from Buy to Hold and lowered the price target from $43.00 to $35.00.NetApp shares slipped 12.28 percent to $30.99 in pre-market trading.Breaking news

• Shares of Best Buy Co Inc (NYSE: BBY) jumped more than 9 percent in pre-market trading after the company reported stronger-than-expected results for the first quarter on Thursday. To read the full news, click here.
• Calithera Biosciences, Inc. (NASDAQ: CALA) today announced that data from its lead, first-in-class program CB-839 will be presented at the 20th Congress of the European Hematology Association (EHA) June 11-15, 2015, in Vienna, Austria. To read the full news, click here.
• Shares of Kirkland's, Inc. (NASDAQ: KIRK) gained more than 3 percent in pre-market trading after the company reported stronger-than-expected earnings for the fiscal first quarter on Thursday. To read the full news, click here.
• Karyopharm Therapeutics Inc. (NASDAQ: KPTI) today announced that two abstracts describing the activity of selinexor (KPT-330), the company's lead drug candidate in development for hematological malignancies and solid tumors, have been selected for presentation at the 20th Congress of the European Hematology Association (EHA) 2015 Annual Meeting taking place June 11 - 14, 2015 in Vienna, Austria. To read the full news, click here.